Home / Private raises / Bond Biosciences, Inc.
Bond Biosciences, Inc.
Other Health Care · Parkville, Missouri · $7.6M sold across 1 offering
Form D filings (1)
| Filed | Form | Sold | Offered | Investors | Exemption | Securities | First sale | |
|---|---|---|---|---|---|---|---|---|
| 2026-10-05 | D/A (update) | $7.6M | $15.0M | 122 | 506(b) | Equity | Apr 1 | SEC ↗ |
An update (D/A) restates the running total of its offering, so the total above counts each offering's latest figure once.
Sold through (placement agents)
| Broker-dealer | Solicited in |
|---|---|
| Stonehaven, LLC Collage Venture Partners, LLC | All States |
Sales commissions $529K in the latest filing.
Issuer
| Industry | Other Health Care |
| Located | Parkville, Missouri |
| Entity | Corporation |
| Incorporated | Delaware |
| SEC CIK | 1824224 |
People named in the latest filing
| Name | Role |
|---|---|
| Michael Beckloff | Director |
| Cory Berkland | Executive Officer, Director |
| Timothy Opler | Director |
| Michael A. Riley | Executive Officer, Director |
| Jay Shepard | Director |
Names and roles as filed with the SEC. Addresses are not shown.
Source: SEC EDGAR Form D filings. Amounts are self-reported by the issuer. Not investment advice.
How are we doing?
